Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
Sign Up to like & getrecommendations! Published in 2020 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2020-000612
Abstract: Background While prophylactic human papillomavirus (HPV) vaccines will certainly reduce the incidence of HPV-associated cancers, these malignancies remain a major health issue. PDS0101 is a liposomal-based HPV therapeutic vaccine consisting of the immune activating cationic… read more here.
Keywords: immunomodulation enhance; therapeutic vaccine; antitumor effects; hpv therapeutic ... See more keywords